Rate My Professor Raj Kumar

Kumar's research bridges clinical oncology and translational science, focusing on biomarker-driven approaches, immunotherapy in lung cancer, and mechanisms of resistance to EGFR inhibitors, with an emphasis on cancer epigenetics. As a co-investigator in the Chatterjee Laboratory at the University of Otago, he collaborates on innovative projects such as developing DNA methylation panels for liquid biopsies to enable early detection and real-time tracking of treatment responses in lung cancer patients. For this work, he and Associate Professor Aniruddha Chatterjee received the 2021 Roche Translational Cancer Research Fellowship. His contributions to the literature include co-authorship on 'Cell-free DNA methylation in the clinical management of lung cancer' (Trends in Molecular Medicine, 2024), 'Comparison of enzymatic and bisulfite-based methods for DNA methylation profiling' (2026), and 'Clinical cancer epigenetics' (2024). These efforts underscore his impact on advancing precision medicine in oncology.